AbCellera to Present Virtually at Berenberg Conference on May 18, 2021
11 Maggio 2021 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present virtually at the Berenberg Conference USA
2021 on Tuesday, May 18, 2021 at 11:00 a.m. Pacific Time.
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera’s Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce costs, and tackle the toughest problems in
drug development. To learn more, please visit us at
www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210511006146/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Kevin
Heyries, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024